Related references
Note: Only part of the references are listed.The NLRP3 inflammasome: a therapeutic target for inflammation-associated cancers
Mahdi Gouravani et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2020)
Sequential ubiquitination of NLRP3 by RNF125 and Cbl-b limits inflammasome activation and endotoxemia
Juan Tang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Expression profile of H3K4 demethylases with their clinical and pathological correlation in patients with clear cell renal cell carcinoma
Aman Kumar et al.
GENE (2020)
The histone demethylase LSD1 promotes renal inflammation by mediating TLR4 signaling in hepatitis B virus-associated glomerulonephritis
Yi-Tong Yang et al.
CELL DEATH & DISEASE (2019)
Reduction in H3K4me patterns due to aberrant expression of methyltransferases and demethylases in renal cell carcinoma: prognostic and therapeutic implications
Aman Kumar et al.
SCIENTIFIC REPORTS (2019)
Correlation Between the NLRP3 Inflammasome and the Prognosis of Patients With LSCC
Yi Xue et al.
FRONTIERS IN ONCOLOGY (2019)
Emerging Activators and Regulators of Inflammasomes and Pyroptosis
Yansong Xue et al.
TRENDS IN IMMUNOLOGY (2019)
Pathogenic and Therapeutic Role of H3K4 Family of Methylases and Demethylases in Cancers
Aman Kumar et al.
INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY (2019)
SUMO-mediated regulation of NLRP3 modulates inflammasome activity
Rachael Barry et al.
NATURE COMMUNICATIONS (2018)
Role of the NLRP3 inflammasome in cancer
Maryam Moossavi et al.
MOLECULAR CANCER (2018)
Inflammasomes: mechanism of action, role in disease, and therapeutics
Haitao Guo et al.
NATURE MEDICINE (2015)
Share Paper
